A Study to Evaluate Efficacy, Safety and Tolerability in Antiretroviral Therapy (ART)-Experienced Participants of at Least 50 Years of Age Living With Human Immunodeficiency Virus (HIV) With Virologic Suppression Who Switch to DTG/3TC FDC From BIC/FTC/TAF
Clinical trial NCT05911360 · COMPLETED
Trial details
- NCT number
- NCT05911360
- Sponsor
- ViiV Healthcare
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2023-07-07
- Primary completion
- 2026-01-23
- Enrollment
- 205
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.